Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A generic and extensible automatic classification framework applied to brain tumour diagnosis in HealthAgents

  • Sáez Silvestre, Carlos|||0000-0003-2678-8249
  • Garcia-Gomez, Juan M
  • Robles Viejo, Montserrat
  • Vicente Robledo, Javier
  • Tortajada Velert, Salvador
  • Luts, Jan
  • Dupplaw, David
  • Van Huffel, Sabine
[EN] New biomedical technologies enable the diagnosis of brain tumours by using non-invasive methods. HealthAgents is a European Union-funded research project that aims to build an agent-based distributed decision support system (dDSS) for the diagnosis of brain tumours. This is achieved using the latest biomedical knowledge, information and communication technologies and pattern recognition (PR) techniques. As part of the PR development of HealthAgents, an independent and automatic classification framework (CF) has been developed. This framework has been integrated with the HealthAgents dDSS using the HealthAgents agent platform. The system offers (1) the functionality to search for distributed classifiers to solve specific questions; (2) automatic classification of new cases; (3) instant deployment of new validated classifiers; and (4) the ability to rank a set of classifiers according to their performance and suitability for the case in hand. The CF enables both the deployment of new classifiers using the provided Extensible Markup Language(1) classifier specification, and the inclusion of new PR techniques that make the system extensible. These features may enable the rapid integration of PR laboratory results into industrial or research applications, such as the HealthAgents dDSS. Two classification nodes have been deployed and they currently offer classification services by means of dedicated servers connected to the HealthAgents agent platform: one node being located at the Katholieke Universiteit Leuven, Belgium and the other at the Universidad Politecnica de Valencia, Spain. These classification nodes share the current set of brain tumour classifiers that have been trained from in vivo magnetic resonance spectroscopy data. The combination of the CF with a distributed agent system constitutes the basis of the brain tumour dDSS developed in HealthAgents., This work was partially funded by the European Commission: HealthAgents (contract no. FP6-2005-IST 027214). Jan Luts is a PhD student supported by an IWT grant. Carlos Saez, Salvador Tortajada and Javier Vicente are PhD students partially supported by the Programa Torres Quevedo from the Ministerio de Educacion y Ciencia, co-founded by the European Social Fund (PTQ-08-01-06817, PTQ-08-01-06802, PTQ05-02-03386). We thank INTERPRET partners for their support and for providing the data used for training some of the classifiers included in the HealthAgents network; in particular we thank C. Majos (IDI-Bellvitge), John Griffiths (SGUL), Arend Heerschap (RU), Witold Gajewicz (MUL), Jorge Calvar (FLENI), Margarida Julia-Sape (UAB) and Carles Arus (UAB). The language revision of this document was funded by the Universidad Politecnica de Valencia. This work has been partially supported by the Health Institute Carlos III through the RETICS Combiomed, RD07/0067/2001.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Extracting MRS discriminant functional features of brain tumors

  • Fuster García, Elíes|||0000-0002-0716-8960
  • Garcia-Gomez, Juan M
  • Tortajada Velert, Salvador
  • Vicente Robledo, Javier
  • Robles Viejo, Montserrat
The current challenge in automatic brain tumor classification based on MRS is the improvement of the robustness of the classification models that explicitly account for the probable breach of the independent and identically distributed conditions in the MRS data points. To contribute to this purpose, a new algorithm for the extraction of discriminant MRS features of brain tumors based on a functional approach is presented. Functional data analysis based on region segmentation (RSFDA) is based on the functional data analysis formalism using nonuniformly distributed B splines according to spectral regions that are highly correlated. An exhaustive characterization of the method is presented in this work using controlled and real scenarios. The performance of RSFDA was compared with other widely used feature extraction methods. In all simulated conditions, RSFDA was proven to be stable with respect to the number of variables selected and with respect to the classification performance against noise and baseline artifacts. Furthermore, with real multicenter datasets classification, RSFDA and peak integration (PI) obtained better performance than the other feature extraction methods used for comparison. Other advantages of the method proposed are its usefulness in selecting the optimal number of features for classification and its simplified functional representation of the spectra, which contributes to highlight the discriminative regions of the MR spectrum for each classification task. © 2012 John Wiley & Sons, Ltd., The authors gratefully acknowledge former INTERPRET and eTUMOUR European project partners. Data providers: Professor B. Celda (Physical Chemistry, University of Valencia, Burjassot, Valencia, Spain); Dr F. A. Howe (St George's University of London, London, UK); Dr D. Monleon (Fundacion Investigacion HCUV-University of Valencia, Valencia, Spain); Professor A. Heerschap (Radboud University, Nijmegen, the Netherlands.); Dr. W. Gajewicz, Professor L. Stefanczyk and Dr J. Fortuniak (Uniwersytet Medycznyw Lodz, Lodz, Poland); Professor J. Griffiths (CR UK Cambridge Research Institute, Cambridge, UK); Professor A. C. Peet (Academic Department of Paediatrics and Child Health, University of Birmingham, Birmingham, UK); Professor W. Semmler (Department of Medical Physics in Radiology, German Cancer Research Center, Heidelberg, Germany); Dr. J. Calvar (Fundacion para la Lucha contra las Enfermedades Neurologicas de la Infancia, Buenos Aires, Argentina); Dr. J. Capellades (Hospital Universitari Germans Trias i Pujol, Badalona, Spain); and Dr. C. Majos (Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain). Data curators: Professor C. Arus, Dr M. Julia-Sape, Dr A. P. Candiota, Dr I. Olier, Ms T. Delgado, Ms J. Martin, Ms M. Camison and Mr A. Perez [all from Grup d'Aplicacions Biomediques de la Ressonancia Magestica Nuclear (GABRMN), Universitat Aut noma de Barcelona (UAB) (GABRMN-UAB) and CIBER-BBN]; and Professor B. Celda, Dra. M. C. Martinez-Bisbal and Dra. B. Martinez-Granados (all from Physical Chemistry, University of Valencia, Burjassot, Valencia, Spain). The authors would also like to thank Dr F. A. Howe and F. Raschke for their suggestions and comments. This work was partially funded by the European Commission: eTUMOUR (contract no. FP6-2002-LIFESCIHEALTH 503094), the HEALTHAGENTS EC project (HEALTHAGENTS) (contract no. FP6-2005-IST 027213).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Effect of feature extraction for brain tumor classification based on short echo time 1H MR spectra

  • Luts, Jan
  • Poullet, Jean-Baptiste
  • Heerschap, Arend
  • Robles, Montserrat
  • Suykens, Johan A.K.
  • Van Huffel, Sabine
  • Garcia-Gomez, Juan M
[EN] This study examines the effect of feature extraction methods prior to automated pattern recognition based on magnetic resonance spectroscopy (MRS) for brain tumor diagnosis. Since individual inspection of spectra is time-consuming and requires specific spectroscopic expertise, the introduction of clinical decision support systems.(DSSs) is expected to strongly promote the clinical use of MRS. This study focuses on the feature extraction step in the preprocessing protocol of MRS when using a DSS. On two independent data sets, encompassing single-voxel and multi-voxel data, it is observed that the use of the full spectra together with a kernel-based technique, handling high dimensional data, or using an automated pattern recognition method based on independent component analysis or Relief-F achieves accurate performances. In addition, these approaches have low cost and are easy to automate. When sophisticated quantification methods are used in a DSS, user interaction should be minimized. The computationally intensive quantification techniques do not tend to increase the performance in these circumstances. The results suggest to simplify the feature reduction step in the preprocessing protocol when using a DSS purely for classification purposes. This can greatly speed up the execution of classifiers and DSSs and may accelerate their introduction into clinical practice., The authors thank the Institute for Molecules and Materials, Analytical Chemistry, Chemometrics Research Department of the Radboud University Nijmegen for preprocessing the MRSI data. Margarida Julia-Sape is gratefully acknowledged for all data management tasks; the clinical partners represented by Dr. Witold Gajewicz (MUL, Lodzi, Poland) and Jorge Andres Calvar (FLENI, Ciudad de Buenos Aires, Argentina) are gratefully acknowledged for providing data. Grant sponsors: Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen), Research Council KUL: GOA-AMBioRICS, Centers-of-Excellence in Optimisation; Grant sponsor: IDO; Grant number: 05/010 EEG-fMRI; Grant sponsor: Flemish Government: FWO; Grant numbers: G.0360.05, G.0519.06, G.0341.07, G.0321.06, G.0302.07; Grant sponsors: ICCoS, ANMMM, IWT; Grant sponsor: Belgian Federal Government: DWTC; Grant numbers: IUAP IV-02 (1996 2001), IUAP V-22 (2002 2006);Grant sponsor: Belgian Federal Science Policy Office;Grant number: IUAP P6/04; Grant sponsor: EU; Grant number: IST-1999-10310; Grant sponsor: BIOPATTERN; Grant number: FP6-2002-IST 508803; Grant sponsor: eTUMOUR; Grant number: FP6-2002-LIFESCIHEALTH 503094; Grant sponsor: HealthAgents; Grant number: FP6-2005-IST 027213; Grant sponsor: FAST; Grant number: FP6-019279-2; Grant sponsor: ESA: Cardiovascular Control; Grant number: Prodex-8 C90242.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Automated Brain Tumor biopsy prediction using single-labeling cDNA Microarrays-based gene expression profiling

  • Castells, Xavier
  • Navarro, Alfredo
  • Acebes, Juan José
  • Godino, Óscar
  • Boluda, Susana
  • Barceló, Anna
  • Robles, Montserrat
  • Ariño, Joaquín
  • Arús, Carles
  • Garcia-Gomez, Juan M
[EN] Aims: Gene signatures obtained from microarray experiments may be of use to improve the prediction of brain tumor diagnosis. Nevertheless, automated and objective prediction with accuracy comparable to or better than the gold standard should be convincingly demonstrated for possible clinician uptake of the new methodology. Herewith, we demonstrate that primary brain tumor types can be discriminated using microarray data in an automated and objective way. Methods: Postsurgical biopsies from 35 patients [17 glioblastoma multiforme (Gbm) and 18 meningothelial meningioma (Mm)] were stored in liquid nitrogen, total RNA was extracted, and cDNA was labeled with Cy3 fluorochrome and hybridized onto a cDNA-based microarray containing 11,500 cDNA clones representing 9300 loci. Scanned data were preprocessed, normalized, and used for predictor development. The predictive functions were fitted to a subset of samples and their performance evaluated with an independent subset. Expression results were validated by means of real time-polymerase chain reaction. Results: Some gene expression-based predictors achieved 100% accuracy both in training resampling validation and independent testing. One of them, composed of GFAP, PTPRZ1, GPM6B and PRELP, produced a 100% prediction accuracy for both training and independent test datasets. Furthermore, the gene signatures obtained, increased cell detoxification, motility and intracellular transport in Gbm, and increased cell adhesion and cytochrome-family genes in Mm, agree well with the expected biologic and pathologic characteristics of the studied tumors. Conclusions: The ability of gene signatures to automate prediction of brain tumors through a fully objective approach has been demonstrated. A comparison of gene expression profiles between Gbm and Mm may provide additional clues about patterns associated with each tumor type., Supported in part by grants from the European Commission (FP6-2002-LIFESCIHEALTH 503094 and IST-2004-27214), the research project MEDIVO2 (MEC, SAF2005-03650), and the Programa de Apoyo a la lnvestigacion y Desarrollo (PAID-00-06 UPV)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

The effect of combining two echo times in automatic brain tumor classification by MRS

  • Garcia-Gomez, Juan M
  • Tortajada, Salvador
  • Vidal, César
  • Julià -Sapé, Margalida
  • Luts, Jan
  • Moreno-Torres, Àngel
  • Van Huffel, Sabine
  • Arús, Carles
  • Robles Viejo, Montserrat
[EN] H-1 MRS is becoming an accurate, non-invasive technique for initial examination of brain masses. We investigated if the combination of single-voxel H-1 MRS at 1.5 T at two different (TEs), short TE (PRESS or STEAM, 20-32 ms) and long TE (PRESS, 135-136 ms), improves the classification of brain tumors over using only one echo TE. A clinically validated dataset of 50 low-grade meningiomas, 105 aggressive tumors (glioblastoma and metastasis). and 30 low-grade glial tumors (astrocytomas grade II, oligodendrogliomas anti oligoastrocytomas) was used to fit predictive models based on the combination of features from short-TEs and long-TE spectra. A new approach that combines the two consecutively was used to produce a single data vector from which relevant features of the two TE spectra could be extracted by means of three algorithms: stepwise, reliefF, and principal components analysis. Least Squares support vector machines and linear discriminant analysis were applied to fit the pairwise and multiclass classifiers, respectively. Significant differences in performance were found when short-TE, long-TE or both spectra combined were used as input. In our dataset, to discriminate meningiomas, the combination of the two TE acquisitions produced optimal performance. To discriminate aggressive tumors from low-grade filial tumours, the use of short-TE acquisition alone was preferable. The classifier development strategy used here lends itself to automated learning and test performance processes, which may, be of use for future web-based multicentric classifier development studies. Copyright (c) 2008 John Wiley & Sons, Ltd., This work was partially funded by the European Commission: eTUMOUR (contract no. FP6-2002-LIFESCI-HEALTH 503094). HealthAgents (contract no. FP6-2005-IST 027213), BIOPATTERN (contract no. FP6-2002-IST 508803); Programa de Apoyo a la Investigacion y Desarrollo, PAID-00-06 UPV; Research Council KUL: GOA-AMBioRICS, Centers-of-excellence optimisation; Belgian Federal Government: DWTC, IUAPV P6/04 (DYSCO 2007-2011). Jan Luts is a PhD student supported by an IWT grant. We thank INTERPRET partners for providing data, in particular, C. Majos (IDI-Bellvitge), John Griffiths (SGUL), Arend Heerschap (RU), Witold Gajewicz (MUL), and Jorge Calvar (FLENI). We also thank Guillem Mercadal for his feedback about 1H MRS data processing.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Multiproject-multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy

  • Garcia-Gomez, Juan M
  • Fuster García, Elíes|||0000-0002-0716-8960
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Luts, Jan
  • Julia-Sape, Margarida
  • Krooshof, Patrick
  • Tortajada Velert, Salvador
  • Vicente Robledo, Javier
  • Melssen, Willem
  • Olier, Ivan
  • Postma, Geert
  • Monleon, Daniel
  • Moreno-Torres, Angel
  • Pujol, Jesus
  • Candiota, Ana-Paula
  • Suykens, Johan
  • Buydens, Lutgarde
  • Celda, Bernardo
  • Van Huffel, Sabine
  • Arus, Carles
  • Robles Viejo, Montserrat
[EN] Automatic brain tumor classification by MRS has been under development for more than a decade. Nonetheless, to our knowledge, there are no published evaluations of predictive models with unseen cases that are subsequently acquired in different centers. The multicenter eTUMOUR project (2004-2009), which builds upon previous expertise from the INTERPRET project (2000-2002) has allowed such an evaluation to take place. A total of 253 pairwise classifiers for glioblastoma, meningioma, metastasis, and low-grade glial diagnosis were inferred based on 211 SV short TE INTERPRET MR spectra obtained at 1.5 T (PRESS or STEAM, 20-32 ms) and automatically pre-processed. Afterwards, the classifiers were tested with 97 spectra, which were subsequently compiled during eTUMOUR. In our results based on subsequently acquired spectra, accuracies of around 90% were achieved for most of the pairwise discrimination problems. The exception was for the glioblastoma versus metastasis discrimination, which was below 78%. A more clear definition of metastases may be obtained by other approaches, such as MRSI + MRI. The prediction of the tumor type of in-vivo MRS is possible using classifiers developed from previously acquired data, in different hospitals with different instrumentation under the same acquisition protocols. This methodology may find application for assisting in the diagnosis of new brain tumor cases and for the quality control of multicenter MRS databases., We would like to thank the INTERPRET and eTUMOUR partners for providing data, particularly, Carles Majos (IDI-Bellvitge), John Griffiths and Franklyn Howe (SGUL), Arend Heerschap (RU), Witold Gajewicz (MUL), Jorge Calvar (FLENI), and Antoni Capdevila (H. de Sant Joan de Deu). This work was partially funded by the European Commission: eTUMOUR (contract no. FP62002-LIFESCIHEALTH 503094), the HEALTHAGENTS EC project (HEALTHAGENTS) (contract no. FP6-2005-IST 027213), BIOPATTERN (contract no. FP6-2002-IST 508803). The authors appreciate the suggestions from the reviewers that have improved the discussion presented in this work. We also thank the following for their contributions: Programa de Apoyo a la Investigacion y Desarrollo, PAID-00-06 UPV; Research Council KUL: GOA-AMBioRICS, Centers-of-excellence optimisation; Belgian Federal Government: DWTC, IUAPV P6/04 (DYSCO 2007-2011); the following participants acknowledge the following: JVR acknowledges to Programa Torres Quevedo from Ministerio de Educacion y Ciencia, co-founded by the European Social Fund (PTQ05-02-03386). JL is a PhD student supported by an IWT grant. DM is supported by the Ministerio de Educacion y Ciencia del Gobierno de Espa a for a Ramon y Cajal 2006 Contract. BC and CA gratefully acknowledge the Ministerio de Educacion y Ciencia del Gobierno de Espa a (BC: SAF2004-06297 and SAF2007-6547; CA: SAF2005-03650). CIBER-BBN is an initiative of the "Instituto de Salud Carlos III" (ISCIII), Spain
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

HealthAgents: distributed multi-agent brain tumor diagnosis and prognosis

  • González-Vélez, Horacio
  • Mier, Mariola
  • Julià-Sapé, Margarida
  • Arvanitis, Theodoros N.
  • Robles Viejo, Monserrat
  • Lewis, Paul H.
  • Dasmahapatra, Srinandan
  • Dupplaw, David
  • Peet, Andrew Charles
  • Arús, Carles
  • Celda Muñoz, Bernardo
  • Van Huffel, Sabine
  • Lluch-Ariet, Magí
  • Garcia-Gomez, Juan M
[EN] We present an agent-based distributed decision support system for the diagnosis and prognosis of brain tumors developed by the HealthAgents project. HealthAgents is a European Union funded research project, which aims to enhance the classification of brain tumors using such a decision support system based on intelligent agents to securely connect a network of clinical centers. The HealthAgents system is implementing novel pattern recognition discrimination methods, in order to analyze in vivo Magnetic Resonance Spectroscopy (MRS) and ex vivo/in vitro High Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS) and DNA micro-array data. HealthAgents intends not only to apply forefront agent technology to the biomedical field, but also develop the HealthAgents network, a globally distributed information and knowledge repository for brain tumor diagnosis and prognosis., First and foremost, we profoundly thank the HEALTHAGENTS Consortium who are ultimately the people in charge of this research endeavor. Without their help and consideration, this article would certainly not have been possible. Second, we thank Francesc Estanyol, Xavier Rafael Palou and Roman Roset for their crucial contribution in the development of the prototype of HEALTHAGENTS, Tiphaine Dalmas for the development of the EbSS, and Jan Luts and Javier Vicente for their comments to the machine learning section. Third, we express our gratitude to the anonymous reviewers who have provided us with feedback to improve the overall quality of the final manuscript. Access to the source code for the Interpret DSS and GUI and for some preprocessing modules is gratefully acknowledged to the Interpret partners. This research has been carried out under the HEALTHAGENTS research grant, funded by the Information Society Technologies priority of the European Union Sixth Framework Programme as an Specific Targeted Research Project with contract no.: IST-2004-27214 (2006– 2008).